Novartis hopes to commercialise "smart lens" within 5 years

ZURICH Tue Jul 15, 2014 2:53pm IST

The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel October 22, 2013. REUTERS/Arnd Wiegmann/Files

The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel October 22, 2013.

Credit: Reuters/Arnd Wiegmann/Files

Related Topics

Stocks

   

ZURICH (Reuters) - Novartis (NOVN.VX) expects the "smart lens" technology it has licensed from Google (GOOGL.O) will take several years to develop, but hopes to have a product ready for market in about five years, the drugmaker's chief executive said on Tuesday.

"This isn't going to happen overnight because it's a breakthrough technology. It's not months, we're probably talking about years. We would hope to be able to commercialise within about five years," Joe Jimenez told Reuters in an interview.

Novartis said earlier on Tuesday it had struck an agreement with Google (GOOGL.O) to develop "smart lens" technology for medical use in the eye.

(Reporting by Caroline Copley and Paul Arnold.)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Reuters Showcase

IBM Chip Unit

IBM Chip Unit

IBM to pay Globalfoundries $1.5 bln to take chip unit  Full Article 

Cost-Cutting

Cost-Cutting

Yahoo set to outline cost-cutting efforts - WSJ.  Full Article 

eBay Board

eBay Board

Marc Andreessen quits eBay board ahead of PayPal spinoff  Full Article 

Cyber Security

Cyber Security

Wall Street urges U.S. regulators' joint cybersecurity approach  Full Article 

Facebook Stake

Facebook Stake

Fidelity Contrafund loads up on Facebook and it pays off  Full Article 

App for Kids

App for Kids

New apps bring kids' playtime back to real world  Full Article 

'Robotic Eyes'

'Robotic Eyes'

Helps Japan's bipedal bot run faster.  Video 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage